Savara, Inc. (SVRA)
4.81
-0.24
(-4.66%)
USD |
NASDAQ |
Oct 02, 16:00
4.815
0.00 (0.00%)
After-Hours: 20:00
Savara Price to Book Value : 6.877 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.877 |
| October 01, 2026 | 7.213 |
| September 30, 2026 | 7.378 |
| September 29, 2026 | 7.263 |
| September 28, 2026 | 7.249 |
| September 25, 2026 | 7.149 |
| September 24, 2026 | 7.249 |
| September 23, 2026 | 7.149 |
| September 22, 2026 | 7.578 |
| September 21, 2026 | 7.792 |
| September 18, 2026 | 7.678 |
| September 17, 2026 | 7.749 |
| September 16, 2026 | 7.335 |
| September 15, 2026 | 7.520 |
| September 14, 2026 | 7.635 |
| September 11, 2026 | 7.578 |
| September 10, 2026 | 7.606 |
| September 09, 2026 | 7.742 |
| September 08, 2026 | 7.907 |
| September 04, 2026 | 7.678 |
| September 03, 2026 | 7.678 |
| September 02, 2026 | 7.806 |
| September 01, 2026 | 7.649 |
| August 31, 2026 | 7.706 |
| August 28, 2026 | 7.520 |
| Date | Value |
|---|---|
| August 27, 2026 | 7.849 |
| August 26, 2026 | 8.021 |
| August 25, 2026 | 8.007 |
| August 24, 2026 | 7.949 |
| August 21, 2026 | 7.992 |
| August 20, 2026 | 7.849 |
| August 19, 2026 | 7.978 |
| August 18, 2026 | 7.678 |
| August 17, 2026 | 7.678 |
| August 14, 2026 | 7.692 |
| August 13, 2026 | 7.535 |
| August 12, 2026 | 8.150 |
| August 11, 2026 | 7.964 |
| August 10, 2026 | 8.192 |
| August 07, 2026 | 8.336 |
| August 06, 2026 | 8.278 |
| August 05, 2026 | 7.878 |
| August 04, 2026 | 7.735 |
| August 03, 2026 | 7.621 |
| July 31, 2026 | 7.806 |
| July 30, 2026 | 7.921 |
| July 29, 2026 | 7.549 |
| July 28, 2026 | 7.621 |
| July 27, 2026 | 7.764 |
| July 24, 2026 | 7.878 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.18 |
| Insmed, Inc. | 32.02 |
| United Therapeutics Corp. | 3.612 |
| Vertex Pharmaceuticals, Inc. | 6.315 |
| ACADIA Pharmaceuticals, Inc. | 2.628 |
Price to Book Value Related Metrics
| PEG Ratio | -0.6729 |
| Price | 4.81 |
| Earnings Yield | -11.99% |
| Market Cap | 987.97M |
| PEGY Ratio | -0.6729 |